article thumbnail

The Market for CEOs: Evidence from Private Equity

Harvard Corporate Governance

A wide range of research examines the market for CEOs and executive mobility in public companies while largely ignoring the market for CEOs in private equity funded companies. We augment the work on public company CEOs by studying the market for CEOs among larger U.S. times on its equity investment.

Equity 263
article thumbnail

Private Equity—2023 Outlook

Harvard Corporate Governance

Despite the challenges the year presented for investors (rising interest rates, tumultuous financial markets, geopolitical upheaval, etc.), private equity showed resilience in 2022. We review below some of the key themes that drove private equity deal activity in 2022 and our expectations for 2023. Deal volumes down.

Equity 232
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Do Equity Markets Care About Income Inequality? Evidence from Pay Ratio Disclosure

Harvard Corporate Governance

financial markets and shareholders assess the dispersion in pay between a firm’s top executives and rank-and-file employees. We find that firms reporting a higher pay ratio experience a significantly lower market reactions than firms reporting a lower pay ratio. However, it is largely unknown how U.S.

Equity 220
article thumbnail

Private Equity in 2023—A Year (Not) to Remember

Harvard Corporate Governance

In our memo early last year, we noted that private equity investors and dealmakers faced considerable uncertainty heading into 2023 following a challenging 2022. Not many would have predicted the rebound in equity markets in the second half of 2023 or the rising (for now) prospects of a soft landing for the broader U.S.

Equity 160
article thumbnail

How to Navigate Equity Plan Proposals

Harvard Corporate Governance

Russell 3000 equity plan proposals are facing historically low shareholder support and higher failure rates in 2023. These headwinds likely reflect both increased shareholder and proxy advisor expectations in equity plan sizing and increased share usage pressure at companies in depressed markets. more…)

Equity 130
article thumbnail

Private Equity and the Corporatization of Health Care

Harvard Corporate Governance

Six decades ago, Nobel economist Kenneth Arrow wrote a seminal article justifying various “nonmarket social institutions” that shielded health services from normal market conditions. For a discussion of Arrow’s theories and evolving health care markets, see this symposium.

Equity 243
article thumbnail

Growth Equity: The Child Prodigy of Private Equity and Venture Capital, or an Artifact of Easy Money?

Brian DeChesare

Over the past few decades, growth equity (GE) has gone from an afterthought to a major asset class for huge investment firms. Some argue that GE offers the best of both worlds: the opportunity to fund innovation and growth – as in venture capital – plus the ability to limit downside risk and invest in proven companies – as in private equity.

Equity 101